ABSTRACT
This selection concludes the volume with a topic that unites themes from throughout the four parts and provides an example of the construction of ethical arguments through a merging of humanistic and scientific knowledge. The selection provides a history of developments in technology and bioethics relative to cloning and embryonic stem cells as a backdrop for an analysis that reaches past low-level questions about clinical risk to broader social and ethical concerns (see selection 54).
